期刊文献+

光动力学治疗子宫颈持续性HPV感染临床疗效对比 被引量:7

Comparison of photodynamic therapy for human papillomavirus infection in cervix
下载PDF
导出
摘要 目的探讨在对子宫颈持续性人乳头瘤样病毒(HPV)感染使用光动力学和激光治疗的疗效对比。方法选取2012年10月—2014年2月在该院妇科通过HPV DNA杂交捕获实验证实其有HPV感染,并且感染持续达6个月以上的148例患者,根据随机数字表将其分为两组,分别采用光动力学法和激光治疗法对对各组患者进行治疗,对比两组患者治疗后的疗效以及不良反应。结果患者治疗后采用新柏氏液基细胞学检测(TCT),光动力学组明显优于激光治疗组(P<0.05);转阴性率以及治愈率上,光动力学组也明显优于激光治疗组(P<0.05);不良反应方面,两组在治疗后不良反应方面,不存在明显的差异(P>0.05)。结论与激光治疗方法相比,光动力学治疗方案有着疗效好,治愈率高且可以重复治疗等优点,并且也无明显的不良反应。 Objective To compare the photodynamic therapy with laser therapy for human papillomavirus (HPV)infection in cervix. Methods Collecting 148 patients who were used by hybrid capture HPV DNA experiments showed that the HPV infection from 2012. 10 to 2014.2 in our hospital,and infected for more than 6 months,according to the random number table,they were divided into two groups,Using photodynamic therapy and laser therapy for the treatment of the patients in each group,comparing the two groups of pa-tients after treatment and adverse reaction.Results New PAT' S detected by liquid based cytology in patients after treatment,photody-namic group was significantly better than the laser treatment group(P 〈0.05);Negative rate and cure rate,photodynamic group was al-so better than the laser treatment group (P 〈0.05);there were no significantly difference in terms of adverse reactions in the two groups after treatment,adverse reactions (P 〉0.05).Conclusion Compared with laser therapy,photodynamic therapy has a good curative effect,high cure rate and can be repeated treatment etc,and has no obvious adverse reaction.
出处 《安徽医药》 CAS 2016年第1期102-105,共4页 Anhui Medical and Pharmaceutical Journal
基金 襄阳市科技计划研究与开发项目(No 2014-9-17)
关键词 光动力学治疗法 激光治疗 人乳头瘤样病毒 宫颈 photodynamic therapy laser treatment cervical human papilloma virus cervix
  • 相关文献

参考文献15

二级参考文献76

共引文献189

同被引文献111

  • 1刘亚利,王晓黎,刘青,崔建华(编校).子宫颈上皮内瘤变保守治疗的临床研究[J].中国妇幼保健,2007,22(5):573-575. 被引量:2
  • 2赵健,杜海军,廖秦平.红色诺卡菌细胞壁骨架对宫颈癌细胞株-HeLa细胞生长的影响[J].中华实验和临床病毒学杂志,2007,21(1):20-22. 被引量:9
  • 3章文华主编.子宫颈病变的诊断要点[M].北京:人民卫生出版社,2006:100-107.
  • 4Poole DN, Tracy JK, Levitz L, et al.A cross-sectional study to assess HPV knowledge and HPV vaccine acceptability in Mal[J].PLos One, 2013 , 8(2) : e56402.
  • 5Shi JF, Belinsan JL, Zhao FH , et al. Human papillomavirus testing for cervical cancer screening: results from a 6-year prospective study in rural China[J]. Am J Epidemiol, 2009, 170(6) : 708-716.
  • 6Martin CM , Astbury K, McEvoy L, et al. Gene expression profiling in cervical cancer:identification of novel markers for disease diagnosis and therapy [J]. Methods Mol Biol, 2009 (511) : 333-359.
  • 7Masayoshi H, Hiromasa F, Sharon JBH, et al. Incidence risk of cervical intraepithelial neoplaia 3 or more severe lesions is a function of human papillomavirus genotypes and severity of cytologic al and histologicalabnorrnal ities in adult Japanese women[J].Int J Caneer,2013,132(2):327-334.
  • 8Kausar NM, Showket HM, Imtaiyaz Hassan BC, et al. Novel missense mutation in FHIT gene:interperpreting the effect in HPV-mediated cervical cancer in India women [J] .Molecular and Cellular Biochemistry , 2010,335 ( 1 ) : 53.
  • 9Neyaz MK, Bharadwaj M , Hussain S, et al. Novel missense mutation in FHIT gene : interperpreting the effect in HPV-mediated cervical cancer in India women [J]. Mole and Cell Biochemi, 2010,335 (2) : 53.
  • 10Banzai C, Nishino K, Quan J, et al.Promoter methylation of DAPK1, FHIT, MGMT, and CDKN2A genes in cervical car- cinoma [ J ]. Inter J of Clioncology, 2013 , 35 (2) : 50.

引证文献7

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部